Scientific innovation in Cell & Gene Therapy (C&GT) is advancing rapidly, sparking hope for patients with rare diseases, cancer, and other debilitating conditions.  The key is knowing where the advances may come from. To stay at the cutting edge of the C&GT space, ARM commissioned Catalyst Healthcare Consulting to conduct a comprehensive industry-based horizon scan that identified the top emerging C&GT technologies poised to impact the industry, patient lives, and regulatory thinking in the next 3-10 years. The horizon scan culminated in a white paper that highlights the scientific background, latest innovations, and regulatory considerations of each of the top technologies. Check it out below.